Migalastat

Metabolites - Migalastat is an alpha-galactosidase A chaperone used for the treatment of Fabry disease in patients with an amenable galactosidase alpha gene (GLA) variant. Reference standards of Migalastat API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => N-Methyl Deoxygalactonojirimycin
    [catalogue_number] => PA 13 2731003
    [category_ids] => ,78,81,123,76,82,
    [chemical_name] => 
    [weight] => 177.2
    [form] => C7H15NO4
    [cas] => 141206-22-6
    [pslug] => 141206-22-6-n-methyl-deoxygalactonojirimycin-pa132731003
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 13 2731003
PA 13 2731003

N-Methyl Deoxygalactonojirimycin


  • Catalogue No.:PA 13 2731003

  • CAS :

    141206-22-6

  • Molecular Formula : C7H15NO4

  • Molecular Weight : 177.2

stdClass Object
(
    [pname] => 1-Deoxy-L-altronojirimycin Hydrochloride
    [catalogue_number] => PA 13 2731004
    [category_ids] => ,78,81,123,76,82,
    [chemical_name] => 
    [weight] => 199.63
    [form] => C6H14ClNO4
    [cas] => 355138-93-1
    [pslug] => 355138-93-1-1-deoxy-l-altronojirimycin-hydrochloride-pa132731004
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 13 2731004
PA 13 2731004

1-Deoxy-L-altronojirimycin Hydrochloride


  • Catalogue No.:PA 13 2731004

  • CAS :

    355138-93-1

  • Molecular Formula : C6H14ClNO4

  • Molecular Weight : 199.63

pharmaffiliates